Literature DB >> 3038934

Measurement of busulfan in plasma by high-performance liquid chromatography.

W D Henner, E A Furlong, M D Flaherty, T C Shea, W P Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3038934     DOI： 10.1016/0378-4347(87)80531-5

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients.

Authors:  Erika Watanabe; Takuro Nishikawa; Kazuro Ikawa; Hiroki Yamaguchi; Takanari Abematsu; Shunsuke Nakagawa; Koichiro Kurauchi; Yuichi Kodama; Takayuki Tanabe; Yuichi Shinkoda; Kazuaki Matsumoto; Yasuhiro Okamoto; Yasuo Takeda; Yoshifumi Kawano
Journal:  Int J Hematol       Date:  2015-08-05       Impact factor: 2.490

2.  Monitoring of Busulphan Concentrations in Children Undergone Hematopoietic Stem Cell Transplantation: Unicentric Experience over 10 years.

Authors:  Maura Faraci; Carmine Tinelli; Edoardo Lanino; Stefano Giardino; Massimiliano Leoni; Marta Ferretti; Elio Castagnola; Monica Broglia; Annalisa De Silvestri; Daniela Di Martino; Antonella Bartoli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

Review 3.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

4.  Gas-chromatographic analysis of busulfan for therapeutic drug monitoring.

Authors:  L Embree; R B Burns; J R Heggie; G L Phillips; D E Reece; J J Spinelli; D O Hartley; N J Hudon; J H Goldie
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.

Authors:  Mitchell E Horwitz; Ashley Morris; Cristina Gasparetto; Keith Sullivan; Gwynn Long; John Chute; David Rizzieri; Jackie McPherson; Nelson Chao
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

6.  Pharmacokinetic and metabolic studies of high-dose busulphan in adults.

Authors:  M Hassan; G Oberg; H Ehrsson; M Ehrnebo; I Wallin; B Smedmyr; T Tötterman; S Eksborg; B Simonsson
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy.

Authors:  H P Bhagwatwar; S Phadungpojna; D S Chow; B S Andersson
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

8.  Pharmacokinetics of high-dose busulfan in children.

Authors:  G Vassal; A Gouyette; O Hartmann; J L Pico; J Lemerle
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.